Trial Profile
A Long-Term Study of JNS020QD in Patients With Chronic Pain.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 01 Jul 2013
Price :
$35
*
At a glance
- Drugs Fentanyl (Primary)
- Indications Pain
- Focus Adverse reactions
- Sponsors Janssen Pharmaceutical KK
- 16 Dec 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 10 Dec 2010 Planned End Date changed from 1 Nov 2010 to 1 Dec 2010 as reported by ClinicalTrials.gov.
- 28 Oct 2010 Trial start date changed from 1 Sep 2008 to 1 Nov 2008 as reported by ClinicalTrials.gov.